ライフサイエンスコーパス: stopper

1 linear chains, and end-capping by the chain-stopper.

2 e-terminated NiPRT and the alkyne-terminated stopper.

3 ing Hood (ASH), SiBI tube connector and mask stopper.

4 aled with a gray butyl rubber lyophilization stopper.

5 hesis that the azine bridge is a conjugation stopper.

6 obe element attached at the 5'-end via a PCR stopper.

7 st relapse and disability progression in DMT stoppers.

8 are wines as well as other liquids with cork stoppers.

9 n was reached with formation of the tube-end stoppers.

10 ll governed by the design of colloidal chain stoppers.

11 e presence of monofunctional colloidal chain stoppers.

12 lar cycloadditions in the formation of their stoppers.

13 mably from zinc oxide fillers present in the stoppers.

14 ntation whether the cultures were sparged or stoppered.

15 ne bridge indeed functions as a "conjugation stopper," an important design concept in our polar mater

16 Time to first relapse among 485 DMT stoppers and 854 stayers was similar (adjusted HR, aHR=1

17 and disability progression events in matched stoppers and stayers were compared using a marginal Cox

18 Dicationic compounds with ester stoppers and tetracationic materials with pyridinium sto

19 elapse and disability progression among 'DMT stoppers' and propensity-score matched 'DMT stayers' in

20 ealed at its funnel and back entrance with a stopper) and the tissue was preserved for 4 days at room

21 1]crown-7 macrocycles at both ends to act as stoppers, and each of the two benzo[21]crown-7 rings is

22 lsion of blood, but the cushions function as stoppers apposing blood flow with near constant thicknes

23 and tetracationic materials with pyridinium stoppers are compared to each other and their dumbbell s

24 benzene in its solvate form acts as rotation stopper, as supported by dynamic characterization using

25 een the binding stations, and a single bulky stopper at one end were synthesized.

26 Studying the size complementarity of the stoppers at the ends of the thread and the cavity of the

27 e, while two CB[7]s behave as supramolecular stoppers, binding to the two outer quaternary ammonium m

28 vior, and self-organization of a cholesterol-stoppered bistable [2]rotaxane containing a cyclobis(par

29 ingle-molecule molecular capsules, and those stoppered by Cl(-).

30 lyether chain carrying 2,6-diisopropylphenyl stoppers by a 4,4'-bipyridinium (BIPY(2+)) unit, is desc

31 l) phosphate, originating in the gray rubber stoppers commonly used as closures in commercial sources

32 We tested 25-ml glass-stoppered, convex-bottomed Erlenmeyer flasks to determin

33 Therefore, we conclude that 25-ml glass-stoppered Erlenmeyer flasks can be used as an appropriat

34 In this issue of Neuron, Stopper et al. (2014) demonstrate that artificially elim

35 G1, G2, and G3, G4 with a relatively bulkier stopper fails to form a [2]pseudorotaxane complex.

36 used as an appropriate substitute for glass-stoppered, flat-bottomed, round glass bottles in the mak

37 seline, and were propensity-score matched to stoppers for age, sex, disability (Expanded Disability S

38 with sustained release tuned by the tube end-stoppers for hours and days.

39 The NMR markers and the triptycene stopper functioned as designed, but half of the guest mo

40 ators involves 1:1 complexation, followed by stoppering, i.e., feet are added to the rig.

41 le is caused by its participation as a chain stopper in supramolecular ring-chain equilibria, and we

42 in the cavity, but the Cl(-) anion acts as a stopper in the upper rim of the cavity, hydrogen-bonded

43 esidue was removed by boiling the vacutainer stoppers in methanol followed by vacuum baking.

44 Triptycene is used as a stopper intended to prevent complete insertion, forcing

45 the outer mouth of the channel pore, thereby stoppering ion flux.

46 r stay at or near the surface, if a suitable stopper is installed at the end of the shaft.

47 ggested that the efficacy of the p-carborane stopper is reduced by the presence of the two relatively

48 Off-flavour development in cork stoppers is a crucial process in maintaining the high qu

49 ically interlocked molecules are prepared by stoppering kinetically the solution-state assemblies of

50 d 1,3-dipolar cycloaddition reactions with a stoppering maleimide group, forming rotaxane and thread,

51 Attachment of a newly developed bulky stopper molecule with a terminal alkyne to CuPRT via a C

52 Subsequent urethane stoppering of one of these complexes afforded a [2]rotax

53 Subsequent stoppering of the interpenetrated assembly allows for th

54 1-pentenyl groups have been grafted onto the stoppers of [c2]daisy chain molecules obtained using a t

55 Photoactivation of "snap-top" stoppers over the pore openings of mesoporous silica nan

56 ingle variety wines and for a given level of stopper permeability, our results also showed that varie

57 rlocked structure, where the newly developed stopper prevents dethreading of the 30-membered wheel fr

58 -ene addition of cysteine and maleimide as a stoppering protocol.

59 related differences according to the type of stopper, providing a wine metabolomics picture of the im

60 vels of permeability were considered for the stoppers, ranging from 0.2 to 1.8 mg/L/year of oxygen tr

61 pecificity of the system originates from the stoppering reaction, based on "click" chemistry, and thu

62 (n-Bu)3-catalyzed esterification reaction as stoppering reactions.

63 When the flat-bottomed, glass-stoppered, round bottle traditionally used to make VDRL

64 Physically-adsorbed dextrin end stoppers secure the intercellular release of brilliant g

65 molecules (G1, G2, G3, and G4) with varying stopper size are used for the studies.

66 or H.G1, H.G2, and H.G3 with a change in the stopper size.

67 ons, to produce [2]pseudorotaxanes which are stoppered subsequently through 1,3-dipolar cycloaddition

68 e preparation consumables such as Vacutainer stoppers, syringe plungers, and sample vial septa.

69 gression was significantly shorter among DMT stoppers than stayers (aHR=1.47, 95% CI 1.18 to 1.84, p=

70 lex comprising acyclic components, namely, a stoppered thread (1) with a central barbiturate motif an

71 ve employed cytochrome C (CytC) as a protein stopper to produce the first well-characterized protein-

72 us yellow fluorescent protein as a molecular stopper to trap LFN (the 30-kDa, 263-residue N-terminal

73 diated decomposition of the dextrin tube-end stoppers triggers the release of the lumen-loaded brilli

74 n using glutathione (GSH) as an oligopeptide stopper, we have employed cytochrome C (CytC) as a prote

75 Stoppers were assembled by first binding photolabile cou

76 relapse and disability progression among DMT stoppers were investigated using a Cox proportional haza

77 Inclusion criteria for DMT stoppers were: age >/=18 years; no relapses for >/=5 yea

78 -specific design rules, we synthesized chain stoppers with controlled reactivity and achieved quantit

79 The use of dibutylamino groups as stoppers yielded the rotaxane precursor in a reasonable